From Clinical Thyroidology® for the Public: Proton-pump inhibitors (PPIs) lower the amount of acid the…
Read More
FOR IMMEDIATE RELEASE December 6, 2024 Contact: Hayley Gray-Hoehn, hayley.gray-hoehn@mail.house.gov Washington, D.C. – Wednesday, U.S….
An estimated 20 million Americans have some form of thyroid disease, but up to 60…
From Clinical Thyroidology® for the Public: Treatment options for Graves’ disease include antithyroid drugs (ATDs),…
From Clinical Thyroidology® for the Public: Recently, more and more physicians have been preferring treating…
Please see the newest in this year’s updates to ATA’s online patient information titles by…
From Clinical Thyroidology® for the Public: Patients with thyroid cancer experience fear similar to patients…
From Clinical Thyroidology® for the Public: Both thyroid disease and chronic kidney disease (CKD) are…
From Clinical Thyroidology® for the Public: Graves’ disease is an autoimmune disease, meaning that the body…
Thyroid Stimulating Podcast Managing Thyroid Adverse Events From Checkpoint Inhibitors Kaniksha Desai, MD; Afreen Shariff,…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.